Sarcura develops a machine platform for the large scale, industrial manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments from thousands of doses per year to hundreds of thousands, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technology to bring bioprocess control to cellular level.
$ 2.5 Millions - $ 5 Millions
Leave a Reply